Feb 01, 2017 13:30 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 01, 2017 -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases,...
OPKO’S GeneDx Announces Research Collaboration with the Wellcome Trust Sanger Institute
Feb 01, 2017 13:30 pm UTC| Business
MIAMI, Feb. 01, 2017 -- (Nasdaq:OPK)OPKO Health, Inc. announced today that its subsidiary and business unit, GeneDx, is entering into a collaboration with the Deciphering Developmental Disorder (DDD) study led by the...
Feb 01, 2017 13:29 pm UTC| Business
– Results from interim analysis of the ACTIVExtend study of postmenopausal women with osteoporosis treated for 18 months with investigational drug abaloparatide-SC in the ACTIVE trial who were transitioned to alendronate...
Ubiquiti Launches Wave 2 Access Point with Market Leading Performance and Price
Feb 01, 2017 13:23 pm UTC| Business
SAN JOSE, Calif., Feb. 01, 2017 -- Ubiquiti Networks, Inc. (Nasdaq:UBNT) (“Ubiquiti”) today announced its first 802.11ac Wave 2 Enterprise Wi-Fi Access Point: the UniFi AC-HD allows Ubiquiti’s rapidly growing base of...
Feb 01, 2017 13:20 pm UTC| Business
CANTON, Mass., Feb. 01, 2017 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced positive topline results from an oral human abuse potential clinical trial, which was designed to evaluate the abuse potential...
Global Smart Elevators Market will reach USD 26.33 Billion by 2022: Zion Market Research
Feb 01, 2017 13:13 pm UTC| Business
Sarasota, FL, Feb. 01, 2017 -- Zion Market Researchhas published a new report titled “Smart Elevators Market by Solution (New Deployment, Modernization, and Maintenance) for Residential, Commercial, Institutional,...
Galectin Therapeutics Announces Achievement of Key Milestones Related to NASH-CX Clinical Trial
Feb 01, 2017 13:10 pm UTC| Business
NORCROSS, Ga., Feb. 01, 2017 -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced it has generated sufficient financing to cover currently...